IHSN Survey Catalog
  • Home
  • Microdata Catalog
  • Citations
  • Login
    Login
    Home / Central Data Catalog / NGA_2014_MCBPIE-EL_V01_M / variable [F6]
central

Impact Evaluation of the Use of Community Volunteers and Patent Medicine Vendors for Malaria Control in Anambra State and Gombe State 2014 -2015, Endline Survey

Nigeria, 2014 - 2015
Get Microdata
Reference ID
NGA_2014_MCBPIE-EL_v01_M
Producer(s)
Pedro Carneiro, Edit V. Velenyi
Metadata
DDI/XML JSON
Created on
Jan 16, 2021
Last modified
Jan 16, 2021
Page views
109779
Downloads
679
  • Study Description
  • Data Dictionary
  • Downloads
  • Get Microdata
  • Data files
  • cdd_release
  • community_release
  • household_release
  • phf_release
  • phfw_release
  • pmv_release

BRAND NAME, INCLUDING DRUG SPECIFICATIONS (brandname_drug5)

Data file: pmv_release

Overview

Valid: 121
Invalid: 0
Type: Discrete
Start: 5362
End: 5410
Width: 49
Range: -
Format: character

Questions and instructions

Categories
Value Category Cases
ARTESUNAT 1
0.8%
Act 1
0.8%
Amalar ( sp ) 2
1.7%
Amalar (sp) 1
0.8%
Amalar(sp) 3
2.5%
Amatem(act) 1
0.8%
Anate(amodiaquine 1
0.8%
Artecxin 1
0.8%
Artemether 1
0.8%
Artemether 20mg/ 120mg 1
0.8%
Artemether Lumefantrine ( ACT ) 1
0.8%
Artemether Lumefantrine (ACT) 1
0.8%
Artemether and Lumefantrine 1
0.8%
Artemether and Lumefantrine ( Act ) 3
2.5%
Artemether and Lumefantrine (Act ) 1
0.8%
Artemether lumefantrine(Act ) 1
0.8%
Artemether lumefantrine(act) 2
1.7%
Artemether+Lumefantrine(ACT) 2
1.7%
Artemetrin 1
0.8%
Artesunat(act) 1
0.8%
Artesunat(artesunate) 1
0.8%
Artesunate 1
0.8%
Artesunate ( ACT ) 2
1.7%
Artesunate ( act ) 1
0.8%
Artesunate Amodiaquine Winthrop 1
0.8%
Artesunate(GMP) 1
0.8%
Arthemeter Lumefantrine ( sp ) 1
0.8%
Arthemeter Lumefantrine (ACT) 1
0.8%
Arthemeter lumefantrin 4x2 daily 1
0.8%
Camosunate 1x1for 3days 1
0.8%
Camosunate ACT 1
0.8%
Coartem ( Act ) 2
1.7%
Coartem ACT 1
0.8%
Coastal ( Artemether and Lumefantrine ) 1
0.8%
Coatal-forte ( Artemether and Lumefantrine ) 1
0.8%
Codisin plus 1
0.8%
Codisin plus ( Dihydroartemisin and piperaquine ) 1
0.8%
Combisunate 1
0.8%
Combisunate 1x1for 3days 1
0.8%
Combisunate Dispersible 1
0.8%
Dupridox (sp ) 1
0.8%
Fralomin Sp 1
0.8%
Grutha fort Act 1
0.8%
Gvither Plus (Artemether lumefantrine ) 1
0.8%
Halfan (halofantrine) 1
0.8%
Ipca (Artemether and Lumefantrine ) 1
0.8%
Ipca (Artemether and Lumefantrine) 1
0.8%
LARIDOX 1
0.8%
Laridox ( sp ) 3
2.5%
Laridox 3stat 1
0.8%
Laridox sp 2
1.7%
Laridox(/SP) 1
0.8%
Laridox(SP) 1
0.8%
Laridox. SP 1
0.8%
Lonart 1
0.8%
Lonart ( ACT ) 1
0.8%
Lonart DS ACT 1
0.8%
Lonart-DS 1
0.8%
Lonart-DS ( Artemether and Lumefantrine ) 1
0.8%
Lumartem 1
0.8%
Lumartem ( ACT ) 1
0.8%
Lumartem ( Act ) 1
0.8%
Lumartem (ACT ) 1
0.8%
Lumartem ACT 2
1.7%
Lumartem(artemether+lumefantrine) 2
1.7%
Malamox (SP ) 1
0.8%
Malareich 3 once 1
0.8%
Malareich ( SP ) 3
2.5%
Malareich ( sp ) 1
0.8%
Malareich(S.P) 1
0.8%
Maldox-(sp ) 1
0.8%
Maloxine 1
0.8%
Maxinfen (SP) 1
0.8%
Md-Artesunate 2
1.7%
Melofan ( sp ) 1
0.8%
Melofan Sp 1
0.8%
P-Alaxin 2
1.7%
P-Alaxin ( Dihydroartemisin and piperaquine ) 1
0.8%
P-Alaxin (ACT) 1
0.8%
P-Alaxin 2 stat 1daily 1
0.8%
SMT-Forte ACT 1
0.8%
SWIDAR 500/25MG 1
0.8%
Salumether (Artemether and Lumefantrine ) 1
0.8%
Sanofi aventis (Artesunate Amodiaquine, ACT) 1
0.8%
Solartep 2
1.7%
Sp 1
0.8%
Swidar 3 once 1
0.8%
Swidar SP:-) 1
0.8%
Swider 1
0.8%
V-Martem (act ) 1
0.8%
Vamirex 1
0.8%
Vamirex60ml 1
0.8%
WAIPA ACT 2
1.7%
Waipa ( ACT ) 2
1.7%
Waipa (ACT) 1
0.8%
Waipa ACT 2
1.7%
Waipa ACT Comprimes 1
0.8%
Waipa(ACT) 1
0.8%
Windrop (Artesunate and Amodiaquine) 1
0.8%
Warning: these figures indicate the number of cases found in the data file. They cannot be interpreted as summary statistics of the population of interest.
Back to Catalog
IHSN Survey Catalog

© IHSN Survey Catalog, All Rights Reserved.